Brown Advisory
KYNB

Brown Advisory’s Kyntra Bio KYNB Stock Holding History

Brown Advisory’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-32,160
Closed -$27.9M – 1095
2021
Q1 		$27.9M Buy
32,160
+8,312
+35% +$8.85M 0.05% 246
2020
Q4 		$22.1M Buy
23,848
+8,484
+55% +$8.92M 0.04% 254
2020
Q3 		$15.8M Buy
+15,364
New +$16.5M 0.03% 258

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Brown Advisory's KYNB Position: Q2 2021 in Review

Brown Advisory sold out of Kyntra Bio (KYNB) in Q2 2021, closing a stake of 32,160 shares — an estimated $27.9M sold.

Brown Advisory first reported a position in KYNB in Q3 2020 and held it in 3 quarters. The position peaked at $27.9M in Q1 2021. 175 funds tracked by Wall St. Rank hold KYNB as of Q2 2021.

  • Brown Advisory reported no remaining Kyntra Bio position as of Q2 2021 after selling out during the quarter.
  • Brown Advisory sold 32,160 Kyntra Bio shares in Q2 2021, an estimated $27.9M.
  • Brown Advisory first reported a position in Kyntra Bio in Q3 2020 and held it in 3 quarters.
  • Brown Advisory's Kyntra Bio position peaked at $27.9M in Q1 2021.
  • 175 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2021.

Based on Brown Advisory's 13F filing for Q2 2021, filed 29 Jul 2021.